Latest 10-K annual reports

PPG Industries reported flat net sales of $15.9 billion in 2025, with income before income taxes increasing by $193 million to $2,045 million, driven by lower restructuring charges and higher selling prices.

Choice Hotels International, Inc. reported a significant increase in income before taxes for 2025, driven by a joint venture acquisition gain and growth in international operations, despite a decline in U.S. RevPAR and room count.

AtriCure, Inc. announced its 2025 annual results, reporting a 14.9% increase in worldwide revenue to $534.5 million, driven by strong adoption of pain management, open ablation, and appendage management products, while net loss significantly narrowed to $11.4 million.

Knight-Swift Transportation Holdings Inc. reports mixed 2025 results with LTL revenue growth and improved Truckload operating ratio, offset by significant impairments and a decline in net income.

Ball Corporation reported increased net sales in 2025 driven by packaging volume and price/mix, but net earnings significantly decreased due to the prior year's aerospace business divestiture.

Vulcan Materials Company delivered robust financial results in 2025, driven by strong aggregates performance and a positive outlook for public and private construction in 2026.

Old National Bancorp achieved significant growth in 2025, with net income up 24.9% and assets increasing by 34.7%, primarily fueled by the successful integration of Bremer Financial Corporation.

BiomX Inc. reported significant losses and a going concern warning, alongside a strategic pivot, workforce reduction, and a new $3.0 million capital raise contingent on stockholder approval.

Quanta Services reported significant financial growth in 2025, driven by increased demand in Electric and Underground & Infrastructure segments, strategic acquisitions, and a substantial increase in backlog.

Goosehead Insurance, Inc. announced a 16% increase in total revenue to $365.3 million and a 17% rise in Total Written Premium to $4.4 billion for the fiscal year ended December 31, 2025, despite a decrease in net income.

Madrigal Pharmaceuticals achieved significant product revenue of $958.4 million in 2025 from its MASH drug Rezdiffra, while expanding its pipeline with new therapeutic candidates.

Autoliv, a leader in automotive safety systems, reported robust financial performance in 2025 with increased sales and earnings, while outlining a cautious outlook for 2026 amidst geopolitical and economic uncertainties.

ProPetro Holding Corp. reports a return to net income in 2025 despite revenue and EBITDA declines in its core services, driven by strategic investments in its new power generation business and a recent capital raise.

IDACORP achieved its eighteenth consecutive year of net income growth in 2025, driven by record retail energy sales and strategic infrastructure investments.

Etsy reports a decline in core marketplace GMS and net income for 2025 amidst macroeconomic pressures, while announcing the sale of Depop and a CEO transition to focus on its flagship platform.

Praxis Precision Medicines announced positive Phase 3 clinical trial results for ulixacaltamide in Essential Tremor and relutrigine in SCN2A/SCN8A DEEs, alongside significant capital raises.

Bandwidth Inc. reported a 1% revenue increase to $754 million in 2025, driven by enterprise voice growth, alongside a net loss of $13 million, and authorized an $80 million share repurchase program.

Laureate Education, Inc. delivered robust financial performance in 2025, driven by increased enrollments and strategic operational efficiencies in Mexico and Peru.

Visteon Corporation reported a 3% sales decline in 2025 but achieved significant new business wins and maintained strong Adjusted EBITDA despite challenging automotive market conditions.

Garrett Motion Inc. reported increased net sales and net income in 2025, driven by strong turbocharger demand and strategic investments in zero-emission technologies, despite ongoing macroeconomic challenges.

Insmed Incorporated reported significant revenue growth in 2025 driven by the launch of BRINSUPRI and international ARIKAYCE sales, alongside substantial investments in its clinical pipeline and R&D.

Pediatrix Medical Group, Inc. reported a significant turnaround in 2025, achieving $165.4 million in net income and $275.6 million in Adjusted EBITDA, driven by strategic portfolio optimization and improved same-unit revenue.

CenterPoint Energy announced an increased 10-year capital plan of $65.5 billion through 2035, alongside net income growth across its Electric and Natural Gas segments for 2025.

NXP Semiconductors reports a 2.7% revenue decrease in 2025 to $12.27 billion, alongside strategic acquisitions in automotive and AI edge systems, and a CEO transition.

SiteOne Landscape Supply reports a 4% increase in Net sales and 23% rise in Net income for fiscal year 2025, driven by acquisitions and strategic initiatives despite market headwinds.

Itron, Inc. announced a significant increase in net income and EPS for 2025, driven by improved margins and strategic acquisitions in resilience and digital construction management.

UDR, Inc. announced a significant increase in net income for 2025, driven by substantial gains from real estate dispositions and solid Same-Store NOI growth, alongside strategic capital management.

Nutra Pharma Corp. reported continued net losses and a significant working capital deficit for fiscal year 2024, raising substantial doubt about its ability to continue as a going concern, while also settling a major SEC lawsuit.

Eversource Energy announced a significant increase in 2025 earnings, driven by regulated business growth and reduced offshore wind losses, while also raising its quarterly common share dividend.

Eversource Energy announced a significant increase in 2025 earnings, driven by regulated business growth and reduced offshore wind losses, while also raising its quarterly common share dividend.